Company Monitoring Page for Amgen

latest headlines for company on cafepharma

Amgen biosimilar debut boosted by UnitedHealthcare coverage switch
Biopharma Dive
Mon, 08/19/19 - 11:52 am
Tags:
insurers, Amgen, biosimilars, Avastin, Herceptin, Roche, UnitedHealthcare
Biopharma's biggest sellers – the oldies that just keep giving
Evaluate Pharma
Sat, 08/17/19 - 01:38 pm
Tags:
Amgen, Enbrel, patents, biologics, Advair, Zantac, Liptor, Plavix
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Pharmaceutical Business Review
Wed, 08/14/19 - 11:13 am
Tags:
Novartis, Sandoz, biosimilars, Amgen, Enbrel, patents, Erelzi
What Enbrel needs to do after its patent win
EP Vantage
Mon, 08/12/19 - 11:48 am
Tags:
Amgen, Enbrel, patents, generics
Enbrel ruling lifts Amgen shares
BioCentury
Sat, 08/10/19 - 02:02 pm
Tags:
Amgen, Enbrel, patents, Sandoz, generics
3 Lung Cancer Stocks That Could Soar in September
Motley Fool
Mon, 08/5/19 - 12:04 am
Tags:
lung cancer, Eli Lilly, Amgen, AstraZeneca
Amgen results beat estimates, lung cancer trial planned
Yahoo/Reuters
Wed, 07/31/19 - 08:49 am
Tags:
Amgen, earnings, clinical trials, lung cancer, AMG510
Lilly's Emgality powers ahead with 'best-in-class' CGRP access
Fierce Pharma
Tue, 07/30/19 - 04:21 pm
Tags:
Eli Lilly, Emgality, migraines, Amgen, Aimovig, Teva Pharmaceutical, Ajovy
AbbVie's Acquisitions Report Card Shows Investors Have a Reason to Worry About the Allergan Buyout
Motley Fool
Sun, 07/21/19 - 04:18 pm
Tags:
Amgen, Allergan, M&A
Roche doomsday is here: Long-feared Herceptin, Avastin biosims bust into U.S. market
Fierce Pharma
Fri, 07/19/19 - 07:28 pm
Tags:
Herceptin, Avastin, Roche, biosimilars, Allergan, Amgen
These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger
Investors Business Daily
Fri, 07/19/19 - 10:44 am
Tags:
Bristol-Myers Squibb, Celgene, M&A, Otezla, Gilead Sciences, Amgen, Regeneron, Eli Lilly, JNJ
Emgality-maker Lilly courts payers with new migraine ER data
Fierce Pharma
Fri, 07/12/19 - 12:22 pm
Tags:
Eli Lilly, Emgality, cluster headache, migraines, Amgen, Novartis, Teva Pharmaceutical, ER
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs
Xconomy
Thu, 07/11/19 - 11:15 pm
Tags:
Alzheimer's disease, BACE inhibitors, Merck, Eli Lilly, AstraZeneca, Amgen, Novartis, Biogen Eisai
German court blocks sale of Sanofi, Regeneron cholesterol drug
Biopharma Dive
Thu, 07/11/19 - 05:25 pm
Tags:
patents, Amgen, Sanofi, Regeneron, Germany, Praluent, Repatha
Amgen/UCB hit another Evenity hurdle, as European regulators fail to back the osteoporosis drug
Endpoints
Fri, 06/28/19 - 10:04 am
Tags:
Amgen, UCB Pharma, FDA, EMA, Europe, osteoporosis, Evenity, romosozumab
3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal
Motley Fool
Tue, 06/18/19 - 11:54 am
Tags:
Pfizer, Array Biopharma, M&A, Amgen, Gilead Sciences, Biogen
Amgen, Lilly, Merck sue HHS to block price disclosures in DTC ads
BioCentury
Fri, 06/14/19 - 06:26 pm
Tags:
HHS, DTC ads, television ads, Merck, Eli Lilly, Amgen
FDA Approves 20th Biosimilar, 5th for Roche’s Herceptin
RAPS.org
Thu, 06/13/19 - 10:37 pm
Tags:
FDA, biosimilars, Roche, Herceptin, Amgen, Kanjinti
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Forbes
Mon, 06/10/19 - 10:31 am
Tags:
The Medicines Company, Amgen, Sanofi, Regeneron, inclisiran, PCSK9 inhibitors
3 takeaways from cancer's biggest conference
Biopharma Dive
Thu, 06/6/19 - 10:03 pm
Tags:
Amgen, KRAS, accelerated approvals, Turning Point Therapeutics, Keytruda, Opdivo, ASCO 2019

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.